Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study (Q82509003)
Jump to navigation
Jump to search
scientific article published on 14 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study |
scientific article published on 14 November 2011 |
Statements
Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study (English)
Charles A Dinarello
Ahmet Gül
Ilknur Tugal-Tutkun
Leonid Reznikov
Bahar Artim Esen
Amer Mirza
Patrick Scannon
14 November 2011